Logo image of LOCL

LOCAL BOUNTI CORP (LOCL) Stock Fundamental Analysis

USA - NYSE:LOCL - US53960E2054 - Common Stock

2.99 USD
+0.1 (+3.28%)
Last: 10/3/2025, 8:04:00 PM
Fundamental Rating

2

Taking everything into account, LOCL scores 2 out of 10 in our fundamental rating. LOCL was compared to 89 industry peers in the Food Products industry. LOCL has a bad profitability rating. Also its financial health evaluation is rather negative. LOCL is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LOCL has reported negative net income.
In the past year LOCL has reported a negative cash flow from operations.
In the past 5 years LOCL always reported negative net income.
LOCL had a negative operating cash flow in each of the past 5 years.
LOCL Yearly Net Income VS EBIT VS OCF VS FCFLOCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

LOCL has a Return On Assets of -30.52%. This is amonst the worse of the industry: LOCL underperforms 82.02% of its industry peers.
Industry RankSector Rank
ROA -30.52%
ROE N/A
ROIC N/A
ROA(3y)-33.45%
ROA(5y)-46.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LOCL Yearly ROA, ROE, ROICLOCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

Looking at the Gross Margin, with a value of 11.10%, LOCL is doing worse than 65.17% of the companies in the same industry.
In the last couple of years the Gross Margin of LOCL has declined.
LOCL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-31.12%
GM growth 5YN/A
LOCL Yearly Profit, Operating, Gross MarginsLOCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

1

2. Health

2.1 Basic Checks

LOCL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LOCL has been increased compared to 1 year ago.
LOCL has more shares outstanding than it did 5 years ago.
LOCL has a worse debt/assets ratio than last year.
LOCL Yearly Shares OutstandingLOCL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
LOCL Yearly Total Debt VS Total AssetsLOCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

LOCL has an Altman-Z score of -1.90. This is a bad value and indicates that LOCL is not financially healthy and even has some risk of bankruptcy.
LOCL has a Altman-Z score of -1.90. This is amonst the worse of the industry: LOCL underperforms 82.02% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.9
ROIC/WACCN/A
WACC3.12%
LOCL Yearly LT Debt VS Equity VS FCFLOCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

LOCL has a Current Ratio of 1.29. This is a normal value and indicates that LOCL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.29, LOCL is doing worse than 65.17% of the companies in the same industry.
LOCL has a Quick Ratio of 1.29. This is a bad value and indicates that LOCL is not financially healthy enough and could expect problems in meeting its short term obligations.
LOCL has a Quick ratio (0.92) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.92
LOCL Yearly Current Assets VS Current LiabilitesLOCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

LOCL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.88%, which is quite good.
LOCL shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.74%.
LOCL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 290.59% yearly.
EPS 1Y (TTM)16.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.67%
Revenue 1Y (TTM)39.74%
Revenue growth 3Y290.59%
Revenue growth 5YN/A
Sales Q2Q%28.17%

3.2 Future

The Earnings Per Share is expected to grow by 23.82% on average over the next years. This is a very strong growth
LOCL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 47.44% yearly.
EPS Next Y54.68%
EPS Next 2Y35.13%
EPS Next 3Y23.83%
EPS Next 5YN/A
Revenue Next Year36.41%
Revenue Next 2Y56.07%
Revenue Next 3Y47.44%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LOCL Yearly Revenue VS EstimatesLOCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
LOCL Yearly EPS VS EstimatesLOCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LOCL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LOCL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LOCL Price Earnings VS Forward Price EarningsLOCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LOCL Per share dataLOCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as LOCL's earnings are expected to grow with 23.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.13%
EPS Next 3Y23.83%

More info and screens

0

5. Dividend

5.1 Amount

LOCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LOCAL BOUNTI CORP

NYSE:LOCL (10/3/2025, 8:04:00 PM)

2.99

+0.1 (+3.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)N/A N/A
Inst Owners3.85%
Inst Owner Change11.81%
Ins Owners10.99%
Ins Owner Change36.37%
Market Cap66.14M
Analysts85
Price Target5.61 (87.63%)
Short Float %1.53%
Short Ratio1.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-87.75%
Min EPS beat(2)-152.1%
Max EPS beat(2)-23.4%
EPS beat(4)0
Avg EPS beat(4)-75.61%
Min EPS beat(4)-152.1%
Max EPS beat(4)-23.4%
EPS beat(8)0
Avg EPS beat(8)-74.31%
EPS beat(12)2
Avg EPS beat(12)-46.81%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.03%
Min Revenue beat(2)-4.31%
Max Revenue beat(2)0.24%
Revenue beat(4)1
Avg Revenue beat(4)-8.79%
Min Revenue beat(4)-21.25%
Max Revenue beat(4)0.24%
Revenue beat(8)1
Avg Revenue beat(8)-12.52%
Revenue beat(12)2
Avg Revenue beat(12)-9.87%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-26.67%
EPS NQ rev (1m)-5.61%
EPS NQ rev (3m)-4.55%
EPS NY rev (1m)-11.6%
EPS NY rev (3m)-0.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.5
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-14.14
EYN/A
EPS(NY)-2.45
Fwd EYN/A
FCF(TTM)-3.06
FCFYN/A
OCF(TTM)-1.55
OCFYN/A
SpS1.99
BVpS-6
TBVpS-7.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.52%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.1%
FCFM N/A
ROA(3y)-33.45%
ROA(5y)-46.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-31.12%
GM growth 5YN/A
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.67%
Cap/Sales 76.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.92
Altman-Z -1.9
F-Score5
WACC3.12%
ROIC/WACCN/A
Cap/Depr(3y)819.05%
Cap/Depr(5y)1599.94%
Cap/Sales(3y)408.44%
Cap/Sales(5y)2027.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.67%
EPS Next Y54.68%
EPS Next 2Y35.13%
EPS Next 3Y23.83%
EPS Next 5YN/A
Revenue 1Y (TTM)39.74%
Revenue growth 3Y290.59%
Revenue growth 5YN/A
Sales Q2Q%28.17%
Revenue Next Year36.41%
Revenue Next 2Y56.07%
Revenue Next 3Y47.44%
Revenue Next 5YN/A
EBIT growth 1Y-3.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.05%
EBIT Next 3Y34.45%
EBIT Next 5YN/A
FCF growth 1Y53.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.44%
OCF growth 3YN/A
OCF growth 5YN/A